Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

Y0001409

Testosterone propionate

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

17β-hydroxy-4-androstène-3-one 17-propionate, 4-androstène même-17β-ol-3-one 17-propionate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C22H32O3
Numéro CAS:
57-85-2
Poids moléculaire :
344.49
Numéro Beilstein :
3221760
Numéro MDL:
MFCD00003653
Code UNSPSC :
41116107
ID de substance PubChem :
329831409
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

testosterone

Fabricant/nom de marque

EDQM

Contrôle du médicament

regulated under CDSA - not available from Sigma-Aldrich Canada

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])OC(=O)CC

InChI

1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1

Clé InChI

PDMMFKSKQVNJMI-BLQWBTBKSA-N

Informations sur le gène

human ... AR(367)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Testosterone propionate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

T0100000

Testosterone, European Pharmacopoeia (EP) Reference Standard

T0240000

Testosterone decanoate, European Pharmacopoeia (EP) Reference Standard

T0250000

Testosterone enantate, European Pharmacopoeia (EP) Reference Standard

T0300000

Testosterone propionate, European Pharmacopoeia (EP) Reference Standard

T0210000

Testosterone caproate, European Pharmacopoeia (EP) Reference Standard

T0260000

Testosterone isocaproate, European Pharmacopoeia (EP) Reference Standard

Y0000696

Testosterone decanoate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0000716

Testosterone isocaproate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001312

Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0001317

Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001313

Testosterone enantate impurity H, European Pharmacopoeia (EP) Reference Standard

1649007

Testosterone propionate, United States Pharmacopeia (USP) Reference Standard

1647001

Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard

1648004

Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard

1646031

Testosterone Related Compound C, United States Pharmacopeia (USP) Reference Standard

1646097

Testosterone Related Compound I, United States Pharmacopeia (USP) Reference Standard

BP702

Testosterone propionate, British Pharmacopoeia (BP) Reference Standard

1646010

Testosterone Related Compound A CIII, United States Pharmacopeia (USP) Reference Standard

BP319

Testosterone decanoate, British Pharmacopoeia (BP) Reference Standard

BP321

Testosterone isocaproate, British Pharmacopoeia (BP) Reference Standard

BP1076

Testosterone, British Pharmacopoeia (BP) Reference Standard

1647012

Testosterone Cypionate Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR2026

Testosterone propionate, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2027

Testosterone, Pharmaceutical Secondary Standard; Certified Reference Material

1647023

Testosterone Cypionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

Y0002163

Testosterone, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002174

Testosterone, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002145

Testosterone impurity I, CRS, European Pharmacopoeia (EP) Reference Standard

PHR9196

5α-Androstan-17β-ol-3-one, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Pictogrammes

Health hazardExclamation markEnvironment
GHS08,GHS07,GHS09

Mention d'avertissement

Danger

Mentions de danger

H302,H351,H360FD,H400

Classification des risques

Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Repr. 1A

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Kyung Pyo Kang et al.
Molecular medicine reports, 9(6), 2061-2068 (2014-04-01)
Inflammation is a key mediator of renal ischemia-reperfusion (IR) injury. Gender disparities have been reported in acute and chronic kidney disease. In particular, males are considered to be more susceptible to renal ischemic injury compared with females according to animal
A B Firdous et al.
Food & function, 5(10), 2632-2645 (2014-08-29)
Prostate cancer incidence and mortality rates have increased over the past years. The purpose of the present study was to examine the molecular mechanism underlying the chemopreventive effects of quercetin on prostate cancer in an in vivo model. Sprague-Dawley male
Lei Wan et al.
Cancer prevention research (Philadelphia, Pa.), 7(12), 1228-1239 (2014-10-16)
Consumption of tomato products containing the carotenoid lycopene is associated with a reduced risk of prostate cancer. To identify gene expression patterns associated with early testosterone-driven prostate carcinogenesis, which are impacted by dietary tomato and lycopene, wild-type (WT) and transgenic
Negar M Ghahramani et al.
Biology of sex differences, 5, 8-8 (2014-07-01)
The biological basis for sex differences in brain function and disease susceptibility is poorly understood. Examining the role of gonadal hormones in brain sexual differentiation may provide important information about sex differences in neural health and development. Permanent masculinization of
E M Beckett et al.
Reproduction (Cambridge, England), 148(2), 199-209 (2014-05-21)
Gestational testosterone treatment causes maternal hyperinsulinemia, intrauterine growth retardation (IUGR), low birth weight, and adult reproductive and metabolic dysfunctions. Sheep models of IUGR demonstrate placental insufficiency as an underlying cause of IUGR. Placental compromise is probably the cause of fetal
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique